€1.7m grant for innovative T1D treatment

DC4U, an immunology company developing innovative treatments for auto-immune diseases and allergies, has been awarded a €1.7m Eurostars (SiaDM) grant, together with a Leiden University Medical Center (LUMC) research group, for the joint development of an innovative treatment for Type 1 diabetes.

The new groundbreaking approach uses – paradoxically – sugars to re-educate the immune response and restore tolerance to the insulin-producing beta cells in the pancreatic islets of Langerhans. This can accelerate the development of a potential cure for Type 1 diabetes.

Professor Bart Roep, Professor of Diabetology, Immunopathology & Intervention and Director of the Dutch National Diabetes Center of Excellence at the Leiden University Medical Center, commented: “I’m thrilled that we’ve been awarded this Eurostars grant, as with this project we will be one important step further in a career-long journey to translate new understanding of the mechanisms leading to Type 1 diabetes to finding a solution for millions of patients suffering from this condition.”

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags